Leadership & Governance

Meet Our Board of Directors

A team of accomplished leaders combining deep pharma domain expertise, digital innovation, and corporate governance excellence — steering Multiplier AI towards its mission of transforming healthcare engagement.

Multiplier AI is backed by an experienced board with decades of leadership across global pharma, healthcare AI, academic research, and enterprise technology. Each director brings strategic depth and functional expertise to guide our Pre-IPO growth journey.

Our Board Members

VK

Vikram Kumar

Managing Director & CEO
Promoter
Multiplier Solutions Pvt. Ltd.

Vikram Kumar is the founding promoter and Managing Director & CEO of Multiplier AI. With over 20 years of experience in pharma marketing and digital engagement, he has built the company from the ground up into a leading AI-powered healthcare marketing platform. He holds a PGDM from IIM Calcutta and a B.Tech from IIT-BHU, combining strong technical and management acumen.

Pharma Marketing AI Strategy IIM Calcutta IIT-BHU
LinkedIn Profile
SP

Saumya Prakash

Co-Founder & Whole Time Director
Promoter
Multiplier Solutions Pvt. Ltd.

Saumya Prakash is the Co-Founder and Whole Time Director of Multiplier AI. A specialist in pharma and healthcare provider marketing, Saumya leads the company's product and client success initiatives. Her expertise in GenAI-powered communications and deep understanding of HCP engagement has been central to Multiplier AI's rapid growth and platform innovation.

HCP Engagement GenAI Product Strategy
LinkedIn Profile
VJ

Dr. Vivek Jha

Independent Director
Eli Lilly & Company

Dr. Vivek Jha is a Senior Director at Eli Lilly & Company with over 20 years of experience in global pharmaceutical strategy, AI adoption, and commercial excellence. He has a deep understanding of pharma marketing technology and regulatory landscape, having led large-scale digital transformation initiatives across emerging and developed markets.

Global Pharma AI Adoption Commercial Excellence
MV

Dr. Madhu Viswanathan

Independent Director
Indian School of Business (ISB)

Dr. Madhu Viswanathan is an Associate Professor at the Indian School of Business (ISB), Hyderabad. She holds a PhD from the Carlson School of Management. Her academic research spans healthcare analytics, consumer behaviour, and data-driven marketing strategies. She brings a rigorous research and governance perspective to the board, with expertise in bridging industry challenges with evidence-based frameworks.

Healthcare Analytics ISB Research
VB

Venkat Kamalakar Bundla

Non-Executive Independent Director
Life Sciences & Corporate Governance

Venkat Kamalakar Bundla brings over 17 years of experience in corporate governance, strategy advisory, and investment in life sciences ventures. As an active angel investor in the healthcare and life sciences space, he has backed multiple early-stage companies and guided them through scale-up and compliance milestones. He provides the board with strong financial oversight and stakeholder management expertise.

Corporate Governance Angel Investor Life Sciences
NA

Namit Agarwal

Independent Director
Healthcare Technology Leadership

Namit Agarwal has over 24 years of experience in healthcare technology, operations, and leadership. He previously served as Chief Information Officer (CIO) and Chief Operating Officer (COO) at Reventics, a US-based healthcare AI company. His extensive background in healthcare IT systems, revenue cycle management, and enterprise software brings a global technology lens to Multiplier AI's board.

Healthcare IT CIO / COO Reventics

Company Promoters

Multiplier AI is founder-led, with both promoters holding significant equity stakes and actively involved in the day-to-day operations and strategic direction of the company.

VK
Vikram Kumar Managing Director & CEO
SP
Saumya Prakash Co-Founder & Whole Time Director

Multiplier AI — On the Path to IPO

We are currently on a Pre-IPO growth trajectory, scaling our AI-powered platform across pharma and hospital clients in India and globally. Our board is committed to best-in-class governance and sustainable value creation for all stakeholders.

Talk to Our Team About Multiplier AI

Our Governance Framework

Regulatory Compliance

Full compliance with DPDP Act, UCPMP guidelines, and applicable SEBI regulations. Our data practices and marketing systems are built on a compliance-first foundation.

Strategic Oversight

The board meets regularly to review financial performance, product roadmap, and market expansion strategy — ensuring accountability and long-term value creation.

Independent Oversight

Four of our six directors are independent, providing unbiased governance and robust checks. Our audit and risk committees operate with full independence and transparency.

Data Security

Enterprise-grade data security policies govern all customer and patient data. Regular audits, access controls, and encryption standards are maintained across all systems.

Stakeholder Trust

We maintain open communication with investors, partners, and clients. Our disclosures and reporting practices are designed for the highest level of trust and transparency.

Ethical AI Practices

All AI systems deployed on our platform are reviewed for bias, accuracy, and healthcare guideline adherence — ensuring ethical, responsible use of artificial intelligence.

Get in Touch With Our Team

Interested in learning more about Multiplier AI's leadership, governance, or Pre-IPO journey? Reach out to us.